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1. INTRODUCTION 
In mammalian skeletal muscle, the rate of protein 
synthesis is subject to regulation by a number of 
hormones, including insulin and glucocorticoids 
[l-5]. These hormones appear to exert their trans- 
lational effects at the level of peptide-chain initia- 
tion [3,4,7]. One of the best characterised examples 
of the regulation of protein synthesis at initiation is 
the inhibition of this process which occurs when 
reticulocyte lysates are deprived of haemin (review- 
ed in [6]). Here, inhibition of protein synthesis is 
associated with increased phosphorylation of an 
initiation factor (eucaryotic . initiation factor- 
2, eIF-2) by a haem-regulated protein kinase 
(haem-controlled repressor, HCR) [7]. The normal 
function of eIF-2 is to promote the binding ‘of the 
initiator tRNA (Met-tRNAf) to the 40 S ribosomal 
subunit. This process involves formation of a ‘ter- 
nary complex’ between eIF-2, Met-tRNArand GTP 
[S]. It appears that phosphorylation of eIF-2 impairs 
its ability to function in these initiation reactions. 
Phosphorylation of eIF-2 may also be involved in 
the regulation of protein synthesis under other 
conditions and in cells other than reticulocytes (re- 
viewed in [9]). 
As a first step in investigating the possibility that 
similar mechanisms involving phosphorylation of 
eIF-2 mediate the hormonal regulation of initiation 
in skeletal muscle, we have purified eIF-2 from this 
tissue. The factor from skeletal muscle shows strong 
similarities to eIF-2 from other sources, and in partic- 
ular it is a substrate for phosphorylation by the 
haem-controlled repressor from reticulocytes. Pre- 
liminary evidence suggests that skeletal muscle also 
contains a protein kinase capable of phosphorylat- 
ing the same subunit (a) of eIF-2 which is phos- 
phorylated by HCR. 
2. MATERIALS AND METHODS 
Abbreviations: Tris, Tris(hydroxymethyl)aminomethane; 
EDTA, ethylenediamine tetraacetic acid; EGTA, ethyl- 
ene glycol bis @-aminoethyl ether)N,N,N’,N’-tetraacetic 
acid; HCR, haem-controlled repressor; eIF-2, eucaryotic 
initiation factor-2; eIF-2a, eIF-2/3, ~‘3 subunits of eIF-2; 
SDS, sodium dodecylsulphate 
The radiochemicals L-[35S]methionine and 
[y-32P]ATP were obtained from the Radiochemical 
Centre (Amersham). Phosphocellulose, GTP, 
ATP, pyruvate kinase (type II from rabbit muscle), 
phosphoenolpyruvate and reagents for polyacryl- 
amide gel electrophoresis were from Sigma Chem- 
ical Co. (Poole). Cellulose nitrate filters (pore size 
0.45 pm) were purchased from Sartorius (Belmont, 
Surrey). Calf liver tRNA was from Boehringer 
(Lewes). Ammonium sulphate (grade for enzyme 
work) was supplied by BDH (Poole). 
* Present address, for correspondence: The Biological 
Laboratory, University of Kent, Canterbury, Kent 
CT2 7NJ, England 
[35S]Methionyl-tRNAr was prepared as in [lo] 
using E. coli aminoacyl-tRNA synthetases. The 
purified haem-controlled repressor was a generous 
gift from Dr Tim Hunt (University of Cambridge). 
Initiation factor eIF-2 (from rat liver) was kindly 
provided by Dr Michael Clemens (St George’s 
Hospital Medical School, London). 
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2.1. Assay of initiation factor eIF-2 subjected to autoradiography using Kodak X-ray 
Initiation factor eIF-2 was assayed by its ability to film. 
form ternary complexes with GTP and Met-tRNAr. 
The formation of these complexes, containing 
[35S]Met-tRNAr, was quantified by their retention 
on cellulose nitrate filters, essentially as in [ 111. A 
typical incubation (50 ~1) contained: 20 mM 
Tris-HC1 (pH 7.6); 0.5 mM magnesium acetate; 
1 mM dithiothreitol; 100 mM KCl; 0.5 mg/ml bovine 
serum albumin; 0.5 mM GTP; 3.0 mM phospho- 
enolpyruvate; 0.2 U pyruvate kinase; and 0.1 pCi 
[35S]Met-tRNAr. Incubations were at 30°C and 
after 15 min a 45 ~1 sample was removed and 
immediately diluted with 1.5 ml buffer containing 
25 mM Tris-HC1 (pH 7.6); 90 mM KC1 and 5 mM 
magnesium acetate. Diluted samples were filtered 
through cellulose nitrate filters, and each was wash- 
ed with a further 10 ml of buffer and then dried 
before measurement of radioactivity. Assays were 
carried out in du licate and corrected for non-spe- 
$5 cific binding of [ S]Met-tRNAf by subtraction of 
the radioactivity bound in assays carried out in the 
absence of GTP, pyruvate kinase and phospho- 
enolpyruvate. One unit of eIF-2 activity mediates 
the binding of one nanomole of Met-tRNAf in the 
standard assay. 
2.4. Preparation of muscle supernatantfractions 
Samples (- 1 g) of rat gastrocnemius muscle 
were homogenised using a Polytron homogeniser (3 
X 10 s) in ice-cold homogenisation medium com- 
prising: 50 mM Tris-HC1 (pH 7.8); 5 mM magne- 
sium acetate; 0.2 mM EDTA; 4 mM sodium pyro- 
phosphate; 0.25 M sucrose; 1 mM dithiothreitol 
and 0.25 M KCl. The homogenates were centrifug- 
ed at 4°C for 10 min at 20000 x g. The resulting 
supematants were then recentrifuged at 135 000 x g 
for 2.5 h at 4°C and the postribosomal superna- 
tants so obtained were stored in liquid nitrogen 
until required. 
2.5. Purification of eIF-2from rabbit skeletal muscle 
The procedure used was derived from that in [ 141 
2.2. Polyacrylamide gel electrophoresis 
Polyacrylamide gel electrophoresis was perform- 
ed using slab gels containing 10% acrylamide/O. 1% 
methylene bis-acrylamide/O. 1% SDS as described 
[ 121 and modified [ 131. 
2.3. Phosphorylation of eIF-2 
Phosphorylation of eIF-2 was carried out in in- 
cubations containing (in 25 pl total vol.): 20 mM 
Hepes (4-(2_hydroxyethyl)- I-piperazine ethane) 
(pH 7.1); 1 mM dithiothreitol; 0.1 mM EDTA; 0.03 
mM EGTA; 2 mM magnesium acetate: 100 mM 
KC1 and HCR, eIF-2 or other components as indi- 
cated. Reactions, at 30°C were started by the ad- 
dition of [Y-~~P]ATP (0.1 mM, 1.2 Ci/mmol). 
After 5 min an equal volume of gel electrophoresis 
buffer, containing 2% SDS and 40 mM dithiothrei- 
tol, was added, and the samples were heated at 
95°C for 5 min. They were then layered onto poly- 
acrylamide slab gels and subjected to electrophor- 
esis, and subsequently stained with Coomassie 
blue/Crocein scarlet. Destained, dried gels were 
for pig liver eIF-2. Male New Zealand White rab- 
bits were given ti lethal dose of Nembutal, and the 
muscle from the back and the hind legs was rapidly 
removed, frozen in liquid nitrogen and stored until 
use, at - 70°C. All subsequent steps were carried 
out at 4°C. Muscle (250 g) was homogenised in 3 
vol. 20 mM triethanolamine-HC1 (pH 7.5); 0.5 M 
KCl; 5 mM magnesium acetate; 2 mM sodium pyro- 
phosphate; 10 mM /3-mercaptoethanol; 0.5 mM 
EGTA in an Atomixer blender at top speed for 3 x 
20 s. The homogenate was centrifuged at 20 000 x g 
for 25 min. The supernatant was filtered through 
glass wool, and then recentrifuged for 16 h at 37 000 
x g.The resulting ‘postribosomal’ supernatant was 
then subjected to ammonium sulphate fractiona- 
tion. Powdered (NH&S04 was added over 3 h to 
achieve 40% saturation. Precipitated proteins were 
removed by centrifugation at 20 000 x g for 30 min. 
The supernatant was made 52% saturated in am- 
monium sulphate (by the slow addition of powder- 
ed (NH&S04) and the precipitated proteins were 
collected by centrifugation for 30 min at 20 000 X g. 
The precipitates were dissolved in - 25 ml buffer A 
(20 mM Tris-HC1 (pH 7.8); 10% (v/v) glycerol; 0.2 
mM EDTA; 10 mM P-mercaptoethanol) contain- 
ing 0.25 M KCl, dialysed extensively against this 
buffer. After dialysis the material was stored at 
- 70°C. 
The stored ammonium sulphate fractions from 4 
of the above purification procedures were thawed, 
combined and applied to a column of phospho- 
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Table 1 
Purification of initiation factor eIF-2 from rabbit skeletal muscle 
Step Volume 
(ml) 
Protein 
(mg) 
Activity 
(U) 
Spec. act. Purification Yield 
(mu/m@ (-fold) (5%) 
1.20000 X supernatant g 1756 18636 7.45 0.40 1 100 
2.37000 X supernatant g 1427 12450 5.08 0.41 1.03 68.0 
3.40-52% (NH4)2S04 fraction 98 1254 2.35 1.87 4.68 31.4 
4. Phosphocellulose (pH 7.8) 14.3 9.8 1.35 138 345 18.0 
5. DEAE-cellulose (pH 7.8) 3.7 0.47 1.42 3020 7550 19.0 
At all steps the protein concentration was determined by the Lowry method [ 151; 880 g rabbit muscle was used in this 
preparation. 
cellulose (6.5 x 2.6 cm) equilibrated in buffer A 
containing 0.25 M KCl. The column was thorough- 
ly washed with this buffer, and the eIF-2 was 
then eluted with buffer A containing 0.7 M KCl. 
Fractions (- 5 ml) were collected and those found 
to contain the highest eIF-2 activities were com- 
bined and dialysed against 2 x 400 ml buffer A 
containing 0.09 M KCl. The dialysed material was 
applied to a small (1.5 x 0.6 ml) DEAE-cellulose 
column. The column was then extensively washed 
with buffer A containing 0.09 M KC1 and then with 
buffer A containing 0.12 M KCl. The eIF-2 was 
then eluted from the column with buffer A con- 
taining 0.18 M KCl. The fractions showing the 
highest eIF-2 activity were divided into 0.05 ml 
aliquots and stored at -‘80” C. 
3. RESULTS AND DISCUSSION 
3.1. PuriJication procedure 
A summary of the purification of eIF-2 from 
rabbit skeletal muscle is shown in table 1. Several 
comments on the determination of eIF-2 activity 
should be made. At steps 1 and 2, dialysis of sam- 
ples prior to assay resulted in an increase in the 
apparent eIF-2 activity, due perhaps to the removal 
of GDP which strongly inhibits ternary complex 
formation [ 161. Also at step 1, eIF-2 activity appear- 
ed to increase as the dilution of the sample in the 
ternary complex assay increased. This is presum- 
ably due to the presence at this stage of non-dialys- 
able factors, e.g., unlabelled Met-tRNAf or mRNA 
1171, which would inhibit the binding of the 
[35S]Met-tRNAf in the eIF-2 assay. Accordingly, 
samples were diluted sufficiently to overcome this 
inhibition. At later stages (4,5) of the procedure, 
where protein concentrations were low, the measur- 
ed eIF-2 activity was increased by the presence in 
the assays of bovine serum albumin (0.5 mg/ml). 
Addition of this protein has no effect on assays at 
earlier stages of the purification, and presumably 
prevents losses of eIF-2 on the walls of the reaction 
tube, as in [ 181. When eIF-2 was assayed as describ- 
ed the overall yield was 15-20s. The purified 
preparation of eIF-2 was stable to storage at 
- 80°C showing no loss of activity over 6 months. 
The purification procedure described here has also 
been successfully applied to the isolation of eIF-2 
from rat skeletal muscle and beef heart muscle 
(C.G.P., unpublished). 
3.2. Characterisation of rabbit muscle eIF-2 
The functional properties of eIF-2 from rabbit 
skeletal muscle were similar to those reported for 
this initiation factor from other sources [ 14,19-2 I], 
in terms of its ability to support formation of tern- 
ary complexes (eIF-2 . GTP . Met-tRNAf) and to 
mediate binding of Met-tRNAf to 40 S ribosomal 
subunits (not shown). Formation of ternary com- 
plexes by muscle eIF-2 was dependent on the pres- 
ence of GTP, was stimulated by a GTP-regenerat- 
ing system (phosphoenolpyruvate plus pyruvate 
kinase) and inhibited by excess MgL+ (0.5-5.0 
mM; not shown). 
When purified muscle eIF-2 was analysed on 
polyacrylamide gels under denaturing conditions, 3 
major protein-staining bands were observed. In ad- 
dition a number of minor components were evident 
57 
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Track 
67- 
36 4 
24- 
Fig.1. SDS-polyacrylamide gel electrophoresis of puri- 
fied rabbit muscle eIF-2. Samples of eIF-2 from step 5 
were subjected to electrophoresis as in section 2: track 1, 
- 11 pg eIF-2; track 2, - 21 pg eIF-2. GEls were stained 
with Coomassie blue/Crocein scarlet. Marker proteins 
(migration positions and Mr-values ( x 10 - 3, indicated 
by arrows) were phosphorylase, bovine serum albumin, 
pyruvate kinase, ovalbumin, glyceraldehyde 3-phosphate 
dehydrogenase and trypsinogen. The arrows labelled 
a, b and c indicate the (Y, p and y subunits of eIF-2, 
respectively. 
(f&.1). The position of the 3 major components 
corresponded to M, 39 000, 5 1 000 and 54 000: 
these components are generally termed the (Y-, p- 
and -r-subunits of eIF-2, respectively. Allowing for 
the well-characterised anomalies in the behaviour 
of the subunits on gel-electrophoresis [22], these 
M,-values are similar to those reported for the 3 
subunits of eIF-2 from other sources [ 14,19-2 11. In 
our experience the resolution of the two larger sub- 
units was variable and on some gels they comigrat- 
ed, so that only two major protein-staining 
58 
bands were observed. Isolation of a fully active 
preparation of eIF-2 containing only two subunits 
has been reported 1231. 
3.3. Phosphorylation of rabbit skeletal muscle eIF-2 
When purified rabbit muscle eIF-2 was incubat- 
ed with [T-~~P]ATP and HCR, the M, 39 000 com- 
ponent of the eIF-2, i.e., the a-subunit, became 
radiolabelled (tig.2, track 3). This was as expect- 
ed, since HCR also phosphorylates the a-subunit of 
rabbit reticulocyte eIF-2 124,251. In the absence of 
HCR, only a trace of radioactivity was detected in 
the positions corresponding to the (Y-, ,B- and y-sub- 
units of eIF-2 (fig. 2, track 2). However, a minor 
component (M, 100 000) present in the eIF-2 pre- 
paration became equally strongly phosphorylated 
in the presence or absence of HCR. The nature of 
this contaminant is unclear: its M, does not corres- 
pond to that of any of the phosphorylatable pro- 
teins of muscle glycogen metabolism. When HCR 
was incubated alone, there was no detectable 
phosphorylation. 
Track - 1 23 4567 8 
a- -a 
Fig.2. Phosphorylation of eIF-2. Incubations including 
[v-~~P]ATP were done as in section 2. After denaturation 
samples were subjected to SDS-polyacrylamide gel 
electrophoresis and autoradiograms of the stained gels 
were prepared as in section 2. Autoradiogram: track 1. 
HCR (8 units/ml [25]) alone; track 2, step 5 rabbit skele- 
tal muscle eIF-2 (3 pg) alone; track 3, step 5 eIF-2 (3 pg) 
plus HCR (8 units/ml); tracks 4-7: experiments with 
skeletal muscle supernatants (6 pi/incubation). Incuba- 
tions also contained rat liver eIF-2 (- 3 pg; tracks 5.7) or 
HCR (8 units/ml, tracks 6,7): track 8, rat liver eIF-2 ( - 3 
pg) alone. The arrows labelled a, b and c indicate the 
migration positions of the n, /!I and y subunits of eIF-2. 
respectively. 
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To investigate whether skeletal muscle itself 
contains a protein kinase capable of phosphorylat- 
ing eIF-2cu, purified eIF-2 (from rat liver) was in- 
cubated with samples of rat muscle supernatants in 
the presence of [y-32P]ATP (fig. 2, tracks 4-7). 
When supernatants or eIF-2 were incubated separ- 
ately little or no incorporation of 32P into eIF-2a 
was apparent (tracks 48). When eIF-2 and super- 
natants were incubated together, it was apparent 
that phosphorylation of eIF-2a had occured (track 
5) indicating that rat muscle does contain eIF-2a 
kinase activity. Some phosphorylation in the posi- 
tion of eIF-2/3 was also evident, in line with 1271 that 
skeletal muscle contains an eIF-2j3 kinase. Inclusion 
of HCR in the incubations resulted in an increase 
specifically in the level of phosphorylation of 
eIF-2a (track 7). 
The observation that muscle eIF-2 is a substrate 
for HCR and that muscle appears to contain an 
eIF-2a kinase, taken with the presence in muscle of 
a potent eIF-2a phosphatase [28], suggest that the 
modulation of eIF-2 activity through changes in its 
phosphorylation state may represent a potential 
control point in the regulation of skeletal muscle 
protein synthesis. 
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